Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis 2022-04-10 18:20
Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL 2022-04-09 04:00
Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene 2022-04-08 21:00
Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand 2022-04-08 21:00
KAZIA THERAPEUTICS ANNOUNCES PRECLINICAL DATA PRESENTED AT AACR CONFERENCE BY JOHNS HOPKINS UNIVERSITY SHOWING ACTIVITY OF PAXALISIB IN PAEDIATRIC BRAIN TUMOURS 2022-04-08 20:30
PENTAX Medical Appoints Dr. Klaus Mergener, MD, PhD, MBA as Chief Medical Officer 2022-04-08 20:00
TWO ABSTRACTS AT AACR CONFERENCE PRESENT DETAILED STUDY DESIGN AND INNOVATIVE BIOMARKER STRATEGY FOR ONGOING PHASE I STUDY OF EVT801 IN ADVANCED CANCER 2022-04-08 20:00
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate 2022-04-08 20:00
CETAPHIL OPTIMAL HYDRATION COMBATS DRY, DEHYDRATED AND SENSITIVE SKIN 2022-04-08 16:27
AGC to Expand Synthetic Pharmaceutical Production Base in Spain 2022-04-08 14:00
WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics 2022-04-08 08:00
SWISS REJU invests in new body contouring technology, further expands Hong Kong's beauty and slimming service offerings 2022-04-08 08:00
New very-high-sensitivity rapid antigen test kits hit Australian market 2022-04-08 06:00
CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer 2022-04-07 23:42
SeekIn Receives CE Mark Approval for LeukoPrint® Molecular Karyotyping Test 2022-04-07 22:22
Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer 2022-04-07 22:21
SIMCERE PHARMA (HK.2096) to host 2022 R&D Day 2022-04-07 21:39
REDCLOUD BIO TO PRESENT PRECLINICAL DATA OF NEXT-GENERATION EGFR TKI H002 AT ANNUAL MEETING OF AMERICAN ASSOCIATION OF CANCER RESEARCH 2022-04-07 19:47
Contract Development and Manufacturing Organizations Shifting Focus to Meet Future Demand 2022-04-07 18:01
Asset Visibility Market Opportunity in the Pharmaceutical Industry Worth US$2.7 Billion by 2026 2022-04-07 16:00
1 265 266 267 268 269 896